Patients with metabolic comorbidities: Autoimmune patients with concurrent insulin resistance, metabolic syndrome, or cardiovascular risk factors benefit doubly, since the GLP-1 addresses both the autoimmune inflammation and the metabolic burden
Others, relying on more conservative default USP guidelines, might assign BUDs as short as 14 days
[PubMed] [Google Scholar] 82.Hudson S., Tabet N
Controlled substance considerations: While GLP-1 medications aren't controlled substances, some states have additional regulations for injectable medications or medications dispensed through telehealth platforms
The tissue sections (5 m) covering whole joints were cut for HE staining and Safranin O staining to assess cartilage destruction
Inject at a 90-degree angle into subcutaneous tissue, not too shallow and not into muscle